This program project will primarily use genetic modified mice. The Animal Core will provide essential genetically modified mice and control wild-type mice to support the research of all four projects. To accomplish this objective, the Animal Core will be responsible for: 1) establishing, maintaining and breeding the required numbers and ages of knock-in, knockout and transgenic mice;2) characterizing gene altered mice using molecular, biochemical, and pathological methods to ensure genotype and phenotypes;3) performing the complex genetic crosses required to obtain mice with the desired combinations of mutations; and 4) providing pups at the desired gestation stages and ages to establish primary culture cells. By coordinating and standardizing animal and cell use among projects, animals, money, and time will be saved. Providing every project with animals and cells derived in the same manner will make it possible to crosscorrelate information from the projects, which will result in synergistic use of the animals and the data generated. The Animal Core will also work closely with the Administrative Core and Core B to help the project leaders plan and/or define their studies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
5P01AG005119-24
Application #
8376722
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4)
Project Start
Project End
2014-03-31
Budget Start
2012-04-01
Budget End
2013-03-31
Support Year
24
Fiscal Year
2012
Total Cost
$224,009
Indirect Cost
$64,036
Name
University of Kentucky
Department
Type
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Hartz, Anika M S; Zhong, Yu; Wolf, Andrea et al. (2016) Aβ40 Reduces P-Glycoprotein at the Blood-Brain Barrier through the Ubiquitin-Proteasome Pathway. J Neurosci 36:1930-41
Ellison, Elizabeth M; Abner, Erin L; Lovell, Mark A (2016) Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease. J Neurochem :
Butterfield, D Allan; Palmieri, Erika M; Castegna, Alessandra (2016) Clinical implications from proteomic studies in neurodegenerative diseases: lessons from mitochondrial proteins. Expert Rev Proteomics 13:259-74
Lovell, Mark A; Abner, Erin; Kryscio, Richard et al. (2015) Calcium Channel Blockers, Progression to Dementia, and Effects on Amyloid Beta Peptide Production. Oxid Med Cell Longev 2015:787805
Sethi, M; Joshi, S S; Webb, R L et al. (2015) Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer's disease. Neuroscience 290:80-9
Barone, Eugenio; Cenini, Giovanna; Di Domenico, Fabio et al. (2015) Basal brain oxidative and nitrative stress levels are finely regulated by the interplay between superoxide dismutase 2 and p53. J Neurosci Res 93:1728-39
Chen, Chun-Hau; Li, Wenzong; Sultana, Rukhsana et al. (2015) Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease. Neurobiol Dis 76:13-23
Bradley-Whitman, Melissa A; Lovell, Mark A (2015) Biomarkers of lipid peroxidation in Alzheimer disease (AD): an update. Arch Toxicol 89:1035-44
Di Domenico, Fabio; Pupo, Gilda; Mancuso, Cesare et al. (2015) Bach1 overexpression in Down syndrome correlates with the alteration of the HO-1/BVR-a system: insights for transition to Alzheimer's disease. J Alzheimers Dis 44:1107-20
Perluigi, Marzia; Pupo, Gilda; Tramutola, Antonella et al. (2014) Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain. Biochim Biophys Acta 1842:1144-53

Showing the most recent 10 out of 238 publications